publicaciones seleccionadas
-
documento
- In vitro antiviral effect of silver nanoparticles against SARS-CoV-2 2022-09-07
- Atorvastatin Effectively Inhibits Ancestral and Two Emerging Variants of SARS-CoV-2 in vitro
- Comparison among plaque assay, tissue culture infectious dose (TCID ) and real-time RT-PCR for SARS-CoV-2 variants quantification
- Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms
- Humoral Response to BNT162b2 Vaccine Against SARS-CoV-2 Variants Decays After Six Months
- Immune characterization of a Colombian familiar cluster of SARS-CoV-2 infection
- In vitro antiviral effect of silver nanoparticles against SARS-CoV-2:
- NK cells fromMen Who Have Sex with Men at high risk for HIV-1 infectionexhibit higher effector capacity
- Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia
- Seronegative MSM at high risk of HIV-1 acquisition show an immune quiescent profile with a normal immune response against common antigens
- Seronegative MSM at high-risk of HIV-1 acquisition show Immune quiescent profile with normal immune response against common antigens
- Sexual Behaviors and Factors Associated with Condomless Sexual Practice in Colombian Men Who Have Sex with Men at High Risk of HIV Transmission
- Toll-Like Receptors as a Therapeutic Target in Cancer, Infections and Inflammatory Diseases